An Innate Immune Regulatory Factor (IIRF) prevents tumorogenesis in a murine melanoma challenge model

Drug Development Research

Volumn 64, Issue 4, 2005, Pages 213-219

  Parker, Todd A ^a   Willeford, Kenneth O ^b   Pharr, G Todd ^b   Hebert, Pamela ^c   Pruett, Stephen B ^c   Wu, Shiyong ^a,d  

^a OHIO UNIVERSITY   (United States)

^b MISSISSIPPI STATE UNIVERSITY   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d 101 Konneker Research Laboratories   (United States)

Author keywords

B16F10; Immunostimulant; Melanoma; NK cells

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; INNATE IMMUNE REGULATORY FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER MODEL; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNOSTIMULATION; MELANOMA; MORPHOMETRICS; MOUSE; NATURAL KILLER CELL; NONHUMAN; SALMONELLA TYPHIMURIUM; SKIN CARCINOGENESIS;

EID: 23244467922     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10434     Document Type: Article

References (23)

1. Cerwenka A, Bakker AB, McClanahan T, Wagner J, Wu J, Phillips JH, Lanier LL. 2000, Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12:721-727.
2. Collier SD, Wu WJ, Pruett SB. 2000. Ethanol suppresses NK cell activation by polyinosinic-polycytidylic acid (poly I:C) in female B6C3F1 mice: role of endogenous corticosterone. Alcohol Clin Exp Res 24:291-299.
3. Comis RL. 2003. A brief history of the research and treatment of lung cancer from 1970 to 2003. Int J Clin Oncol 8:230-233.
4. Friedberg JS, Kaiser LR. 1997. Epidemiology of lung cancer. Semin Thorac Cardiovasc Surg 9:56-59.
5. Herberman RB, Ortaldo JR. 1981. Natural killer cells: their roles in defenses against disease. Science 214:24-30.
6. Izevbigie EB. 2003. Discovery of water-soluble anticancer agents (edotides) from a vegetable found in Benin City, Nigeria. Exp Biol Med (Maywood) 228:293-298.
7. Karre K. 2002. Immunology. A perfect mismatch. Science 295:2029-2031.
8. Moller TR, Ceberg J, Einhorn N, Lindholm C, Nylen U, Svensson H. 2003. Radiotherapy techniques in current use in Sweden. Acta Oncol 42:376-386.
9. Oberg L, Johansson S, Michaelsson J, Tomasello E, Vivier E, Karre K, Hoglund P. 2004. Loss or mismatch of MHC class I is sufficient to trigger NK cell-mediated rejection of resting lymphocytes in vivo: role of KARAP/DAP12-dependent and -independent pathways. Eur J Immunol 34:1646-1653.
10. Parker TA, Willeford KO, Parker S, Buddington K. 2002. Reducing mortality in Salmonella enterica serovar Typhimurium-infected mice with a tripeptidic serum fraction. Antimicrob Agents Chemother 46:1971-1973.
11. Robertson MJ, Ritz J. 1990. Biology and clinical relevance of human natural killer cells. Blood 76:2421-2438.
12. SAS Institute I. 1997. SAS/STAT software: changes and enhancements through release 6.12. Cary, NC: SAS Institute, Inc.
13. Schally AV, Nagy A. 1999. Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors. Eur J Endocrinol 141:1-14.
14. Siren J, Sareneva T, Pirhonen J, Strengell M, Veckman V, Julkunen I, Matikainen S. 2004. Cytokine and contact-dependent activation of natural killer cells by influenza A or Sendai virus-infected macrophages. J Gen Virol 85:2357-2364.
15. Slifka MK, Pagarigan RR, Whitton JL. 2000. NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells. J Immunol 164:2009-2015.
16. Timonen T. 1997. Natural killer cells: endothelial interactions, migration, and target cell recognition. J Leukoc Biol 62:693-701.
17. Trinchieri G, Scott P 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions. Res Immunol 146:423-431.
18. Vivier E, Tomasello E, Paul P. 2002. Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition? Curr Opin Immunol 14:306-311.
19. Willeford KO, Parker TA, Peebles ED, Wang C, Jones EW. 2000. Reduction of mortality in specific-pathogen-free layer chickens by a caprine serum fraction after infection with Pasteurella multocida. Poult Sci 79:1424-1429.
20. Willeford KO, Parker TA, Pharr GT, Buddington K. 2001. Prophylactic effects of a caprine serum factor (CSF-I) in mice infected with Salmonella typhimurium. Drug Dev Res 54:45-51.
21. Williams MD, Sandler AB. 2001. The epidemiology of lung cancer. Cancer Treat Res 105:31-52.
22. Wu WJ, Pruett SB. 1999. Ethanol decreases host resistance to pulmonary metastases in a mouse model: role of natural killer cells and the ethanol-induced stress response. Int J Cancer 82:886-892.
23. Xu RH, Peng XE, Chen GZ, Chen GL. 1992. Effects of cordyceps sinensis on natural killer activity and colony formation of B16 melanoma. Chin Med J (Engl) 105:97-101.